Patents, Parallel Importation and Compulsory Licensing of HIV/AIDS Drugs: The Experience of Kenya Harvard Case Solution & Analysis

Introduction

The paper “Patents, Parallel Importation and Compulsory Licensing of HIV/AIDS Drugs: The Experience of Kenya” basically discusses the different patents, the WTO Agreements on the  Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the Kenya Industrial Property Act which have been considered as the scapegoats in the issues that are regarding the AIDS drugs in the country of Kenya.

Along with this, the paper discusses the fact that the number of deaths due to AIDS has increased quite considerably. AIDS in Kenya is generally all about the competitiveness, the development, the productivity and the survival. The country has been deprived of people who can actually serve as the survival for the increasing number of deaths that occur in the country due to AIDS.

Moreover, AIDS has been a disease that has been a common issue where most of the underdeveloped countries have been unable to get hold of. In fact, it has been one issue or health issue which leads to high death percentage across the country Kenya.

Identification of the stakeholders in the article

The article looks to present quite a few stakeholders that have been discussed in the article. The article basically looks to identify the stakeholders who are either directly or even indirectly related to the issue presented in the article. The paper explains the stakeholders which also include the local stakeholders and even the external stakeholders.

The first and the foremost stakeholder that has been discussed in the paper is the Kenyan Government. The government has been an active member and a local stakeholder that has been initiated in ensuring that the country introduces different rules and regulation that shall help the country reduce and even remove the AIDS in the country.

Moreover, another stakeholder identified in the article is the world health organization (WHO) which again has to consider as a major stakeholder that looks to safeguard the rights and tries to overcome the issues regarding the AIDS within the country. Since WHO is the working worldwide, it has the most obvious role to play in the prevention of the disease.

Another stakeholder is the pharmaceutical company. The most renowned one discussed in the paper is the Glaxo Smith Kline. The company has been offering quite a few medicines in this regard where they actually want to work upon the elimination and decrease in the percentage of deaths that generally occur because of the AIDS.

Moreover, Cosmos industries have also been discussed in the article which has been looking to issue them the license. The company has played the most integral and the most necessary role in making sure that the government should rather allow licensing.

Along with this, the different NGOs have also been involved and discussed in the article such as the Medicines Sans Frontiers (MSF). This has also been trying to find out ways where the different nongovernmental organizations and units have explored the opportunity presented in the article.

Along with this, another Kenya stakeholder that has been discussed in the paper is the Industrial Property Institute (KIPI). Moreover, it also includes the stakeholders which are the ministry of health and the ministry of the trade and industry.

Viewpoints of the stakeholders

The different stakeholders that have been discussed in the paper have different viewpoints. However, the major viewpoints that have been discussed in the paper by different stakeholders are all related to the overall improvement in the prevention of AIDS. Moreover, the major aspects which have been taken by the Kenyan government have been related to introducing different treaties in support and help of the WTO and WHO.

Along with this, the main concern which has been accessed to the medicines and the public health and nutrition which also encourages with the patent protection that helps in the encouragement and the patent encouragement. The overall relaxation from the research and development has also been a major support for the company.

Patents, Parallel Importation and Compulsory Licensing of HIVAIDS Drugs The Experience of Kenya Case Solution

            Along with this, the multinational companies such as the Glaxo Smith Kline have been introducing different medicines to support the AIDS prevention. It has been one of the major decisions which have to be taken by the government to reduce the percentage of deaths through the AIDS.

Along with this, the different licenses have also been introduced by the stakeholders such as the Cosmos industries which look to support the cause of preventing AIDS in the country. Moreover, the different NGOs have also been in the country that has been supporting the country in help and support of the country........................

This is just a sample partial case solution. Please place the order on the website to order your own originally done case solution.

Related Case Solutions & Analyses:

Product Innovation at Aguas Danone Capitec Bank: Leveraging Banking Innovations to Attract Wealthier Customers Release the Constraints: Solving the Problems of Export Financing in Troublesome Times Indian and Northern Affairs Canada – The New Horizon Farms Dilemma Fortis Inc. and the Chalillo Dam Hocol GUIDESlines: Benchmark Values for the GUIDES Framework Resuming Internationalization at Starbucks Risk Management 2.0: Reassessing Risk in an Interconnected World One Firm One Future at Davis Langdon (A)